ArticleJournal of translational medicine2023

HDAC inhibitor ITF2357 reduces resistance of mutant-KRAS non-small cell lung cancer to pemetrexed through a HDAC2/miR-130a-3p-dependent mechanism.

Jian Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.